Direktorat Registrasi ObatValid

PULMEERA

BPOM Number: DKL2558300343A1
Approved: 7 June 2026
Expiry: 3 July 2030
Form: SUSPENSI INJEKSI

About This Registration

PULMEERA is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL2558300343A1. Its current registration status is Valid, with the licence valid until 3 July 2030. The product is registered to BIOTIS PHARMACEUTICALS INDONESIA - INDONESIA. BPOM first approved this registration in June 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 1 VIAL @ 5 DOSIS
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

BIOTIS PHARMACEUTICALS INDONESIA - INDONESIA
KAB. BOGOR
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

BIOTIS PHARMACEUTICALS INDONESIA - INDONESIA
KAB. BOGOR
primary
View profile →

Ingredients (49)

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO DIPTHERIA TOXOID<PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO DIPTHERIA TOXOID&LTBR>BR&GTPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO DIPTHERIA TOXOID<PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO DIPTHERIA TOXOID&LTBR>BR&GTPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO TETANUS TOXOID<PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO TETANUS TOXOID&LTBR>BR&GTPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO TETANUS TOXOID<PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO TETANUS TOXOID&LTBR>BR&GTPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO TETANUS TOXOID<PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO TETANUS TOXOID&LTBR>BR&GTPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO TETANUS TOXOID<PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO TETANUS TOXOID&LTBR>BR&GTPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO DIPTHERIA TOXOID<PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO DIPTHERIA TOXOID&LTBR>BR&GTPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO DIPTHERIA TOXOID<PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO DIPTHERIA TOXOID&LTBR>BR&GTPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO TETANUS TOXOID<PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO TETANUS TOXOID&LTBR>BR&GTPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO TETANUS TOXOID<PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO TETANUS TOXOID&LTBR>BR&GTPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO DIPTHERIA TOXOID<PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO DIPTHERIA TOXOID&LTBR>BR&GTPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO DIPTHERIA TOXOID<PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO DIPTHERIA TOXOID&LTBR>BR&GTPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO TETANUS TOXOID

Market Intelligence

Owner Portfolio: BIOTIS PHARMACEUTICALS INDONESIA - INDONESIA holds 4 BPOM registrations
Manufacturer Scale: BIOTIS PHARMACEUTICALS INDONESIA - INDONESIA produces 4 registered products
Registration Age: Registered for 3 months